Letters are only published if approved by our
editors. Views expressed in letters are not
necessarily endorsed by GroundUp.
We may edit letters for typos, grammar and
style. We also may change the title of the letter.
This is a letter in response to
Drug offers new option for patients with TB and Aids.
Title of your letter: At least 5 and no more than 55 characters.
Text of your letter:
Blank lines separate paragraphs. You can use URLs but not HTML. At least 140 and no more than 2,100 characters (about 340 words).
Yours sincerely: Your real name(s) and, if you wish, title(s) and designation(s). At least 5 and no more than 200 characters.
Your email address: This will neither be displayed nor shared with any third party.